Literature DB >> 6343877

Severe hypoglycemia and hyperinsulinemia in falciparum malaria.

N J White, D A Warrell, P Chanthavanich, S Looareesuwan, M J Warrell, S Krishna, D H Williamson, R C Turner.   

Abstract

We studied the occurrence, clinical manifestations, and mechanism of hypoglycemia in patients with falciparum malaria in eastern Thailand. Hypoglycemia, which was often severe and recurrent, occurred in 17 patients, including 12 in a series of 151 patients with cerebral malaria. Thirty episodes were investigated. Plasma concentrations of insulin and C peptide were inappropriately high, and lactate and alanine concentrations were significantly higher than in patients with falciparum malaria who were normoglycemic (P less than 0.05). Sixteen patients had received quinine; plasma quinine and insulin concentrations were correlated at the time of hypoglycemia (P = 0.007). In seven healthy fasting volunteers intravenous quinine increased the mean plasma insulin concentration (+/- S.D.) from 8.9 +/- 3.1 to 17.1 +/- 8.4 mU per liter (P = 0.02) and reduced the mean plasma glucose concentration from 88 +/- 20 to 68 +/- 23 mg per deciliter (P = 0.002). Our observations indicate that in falciparum malaria quinine-induced insulin secretion may precipitate hypoglycemia, but other factors, including the large glucose requirements of the malaria parasites may also contribute. This important complication, associated with pregnancy and severe disease, must be excluded in all patients with falciparum malaria who have impaired or deteriorating consciousness.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6343877     DOI: 10.1056/NEJM198307143090201

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  82 in total

1.  Hypoglycaemia in Sudanese children with cerebral malaria.

Authors:  G S Atabani; B O Saeed; B A elSeed; M A Bayoumi; N H Hadi; Y A Abu-Zeid; R A Bayoumi
Journal:  Postgrad Med J       Date:  1990-04       Impact factor: 2.401

2.  With commentary.

Authors:  E Alberman
Journal:  Arch Dis Child       Date:  1984-10       Impact factor: 3.791

Review 3.  Cerebral malaria.

Authors:  C R Newton; T T Hien; N White
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

Review 4.  Antimalarial agents: specific treatment regimens.

Authors:  D J Krogstad; B L Herwaldt; P H Schlesinger
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

5.  Ingested human insulin inhibits the mosquito NF-κB-dependent immune response to Plasmodium falciparum.

Authors:  Nazzy Pakpour; Vanessa Corby-Harris; Gabriel P Green; Hannah M Smithers; Kong W Cheung; Michael A Riehle; Shirley Luckhart
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

6.  Human IGF1 extends lifespan and enhances resistance to Plasmodium falciparum infection in the malaria vector Anopheles stephensi.

Authors:  Anna Drexler; Andrew Nuss; Eric Hauck; Elizabeth Glennon; Kong Cheung; Mark Brown; Shirley Luckhart
Journal:  J Exp Biol       Date:  2013-01-15       Impact factor: 3.312

Review 7.  Adverse effects of antimalarials. An update.

Authors:  G A Luzzi; T E Peto
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

8.  Hypoglycaemia and cerebral malaria.

Authors:  C F Kiire
Journal:  Postgrad Med J       Date:  1986-05       Impact factor: 2.401

9.  Insulin regulates aging and oxidative stress in Anopheles stephensi.

Authors:  Mi-Ae Kang; Tiffany M Mott; Erin C Tapley; Edwin E Lewis; Shirley Luckhart
Journal:  J Exp Biol       Date:  2008-03       Impact factor: 3.312

10.  Quinine pharmacokinetics and toxicity in pregnant and lactating women with falciparum malaria.

Authors:  R E Phillips; S Looareesuwan; N J White; K Silamut; S Kietinun; D A Warrell
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.